IntervaOpen the desk

World Health Organization · Health

Trinidad and Tobago: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age

97percent · 2025+5.4% since 2015

Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). WHO Global Health Observatory indicator PCV3. Annual figures for Trinidad and Tobago from 2008 to 2025.

20082025

Every year

YearValue (percent)Note
202597
202491
202394
202293
202196
202095
201993
201899
201793
201691
201592
201495
201380
201241
20110
20100
20090
20080

Source

Published by World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. Retrieved 2026-11-08.

The dataset for every country, with quality and provenance →

Cite or download

World Health Organization (2026). Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age. Interva. https://interva.co/dataset/who-pcv3 (accessed 2026-11-14). catalog snapshot 2026-11-08.

JSON, Trinidad and TobagoAPI and MCP

Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age in other countries

Rank Trinidad and Tobago against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.

Trinidad and Tobago: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (2008–2025) · Interva